These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 7595501)

  • 1. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation.
    Hensley K; Hall N; Subramaniam R; Cole P; Harris M; Aksenov M; Aksenova M; Gabbita SP; Wu JF; Carney JM
    J Neurochem; 1995 Nov; 65(5):2146-56. PubMed ID: 7595501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
    Smith CD; Carney JM; Starke-Reed PE; Oliver CN; Stadtman ER; Floyd RA; Markesbery WR
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10540-3. PubMed ID: 1683703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein oxidation in the brain in Alzheimer's disease.
    Aksenov MY; Aksenova MV; Butterfield DA; Geddes JW; Markesbery WR
    Neuroscience; 2001; 103(2):373-83. PubMed ID: 11246152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease.
    Butterfield DA; Hensley K; Cole P; Subramaniam R; Aksenov M; Aksenova M; Bummer PM; Haley BE; Carney JM
    J Neurochem; 1997 Jun; 68(6):2451-7. PubMed ID: 9166739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
    Castegna A; Aksenov M; Aksenova M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    Free Radic Biol Med; 2002 Aug; 33(4):562-71. PubMed ID: 12160938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative modification of creatine kinase BB in Alzheimer's disease brain.
    Aksenov M; Aksenova M; Butterfield DA; Markesbery WR
    J Neurochem; 2000 Jun; 74(6):2520-7. PubMed ID: 10820214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease.
    Koppal T; Drake J; Yatin S; Jordan B; Varadarajan S; Bettenhausen L; Butterfield DA
    J Neurochem; 1999 Jan; 72(1):310-7. PubMed ID: 9886083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease.
    Butterfield DA; Yatin SM; Varadarajan S; Koppal T
    Methods Enzymol; 1999; 309():746-68. PubMed ID: 10507060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging- and oxygen-induced modifications in brain biochemistry and behavior.
    Carney JM; Smith CD; Carney AM; Butterfield DA
    Ann N Y Acad Sci; 1994 Nov; 738():44-53. PubMed ID: 7832454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
    Butterfield DA; Poon HF; St Clair D; Keller JN; Pierce WM; Klein JB; Markesbery WR
    Neurobiol Dis; 2006 May; 22(2):223-32. PubMed ID: 16466929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
    Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
    Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nuclear DNA oxidation in the brain in Alzheimer's disease.
    Gabbita SP; Lovell MA; Markesbery WR
    J Neurochem; 1998 Nov; 71(5):2034-40. PubMed ID: 9798928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach.
    Newman SF; Sultana R; Perluigi M; Coccia R; Cai J; Pierce WM; Klein JB; Turner DM; Butterfield DA
    J Neurosci Res; 2007 May; 85(7):1506-14. PubMed ID: 17387692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone.
    Carney JM; Starke-Reed PE; Oliver CN; Landum RW; Cheng MS; Wu JF; Floyd RA
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3633-6. PubMed ID: 1673789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders.
    Aksenova MV; Aksenov MY; Payne RM; Trojanowski JQ; Schmidt ML; Carney JM; Butterfield DA; Markesbery WR
    Dement Geriatr Cogn Disord; 1999; 10(2):158-65. PubMed ID: 10026391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein oxidation and enzyme activity decline in old brown Norway rats are reduced by dietary restriction.
    Aksenova MV; Aksenov MY; Carney JM; Butterfield DA
    Mech Ageing Dev; 1998 Jan; 100(2):157-68. PubMed ID: 9541136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased 5S rRNA oxidation in Alzheimer's disease.
    Ding Q; Zhu H; Zhang B; Soriano A; Burns R; Markesbery WR
    J Alzheimers Dis; 2012; 29(1):201-9. PubMed ID: 22232003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.
    Castegna A; Aksenov M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    J Neurochem; 2002 Sep; 82(6):1524-32. PubMed ID: 12354300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-tert-butyl-alpha-phenylnitrone and 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (Tempol).
    Howard BJ; Yatin S; Hensley K; Allen KL; Kelly JP; Carney J; Butterfield DA
    J Neurochem; 1996 Nov; 67(5):2045-50. PubMed ID: 8863512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.